These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

525 related items for PubMed ID: 17508684

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. A/H1N1 flu pandemic. Antiviral drugs: distinguish treatment from prophylaxis.
    Cowling BJ, Ng S, Longini IM.
    BMJ; 2009 Sep 08; 339():b3620. PubMed ID: 19737833
    [No Abstract] [Full Text] [Related]

  • 44. Pandemic flu vaccine: are we doing enough?
    Campbell JD.
    Clin Pharmacol Ther; 2007 Dec 08; 82(6):633-5. PubMed ID: 17998908
    [Abstract] [Full Text] [Related]

  • 45. Antiviral treatment and vaccination for influenza A(H1N1)pdm09 virus: lessons learned from the pandemic.
    López-Medrano F, Fariñas MC, Payeras A, Pachón J.
    Enferm Infecc Microbiol Clin; 2012 Oct 08; 30 Suppl 4():49-53. PubMed ID: 23116793
    [Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Mitigation of pandemic influenza: review of cost-effectiveness studies.
    Lugnér AK, Postma MJ.
    Expert Rev Pharmacoecon Outcomes Res; 2009 Dec 08; 9(6):547-58. PubMed ID: 19941432
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis--North Carolina, 2009.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2009 Sep 11; 58(35):969-72. PubMed ID: 19745803
    [Abstract] [Full Text] [Related]

  • 50. Optimal control for pandemic influenza: the role of limited antiviral treatment and isolation.
    Lee S, Chowell G, Castillo-Chávez C.
    J Theor Biol; 2010 Jul 21; 265(2):136-50. PubMed ID: 20382168
    [Abstract] [Full Text] [Related]

  • 51. Antiviral drugs for influenza.
    Med Lett Drugs Ther; 2009 Nov 16; 51(1325):89-92. PubMed ID: 20220738
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. [French general practitioners' perceptions and use of neuraminidase inhibitors during the pandemic A(H1N1)2009 influenza].
    Barthe J, Noyelle C, Partouche H.
    Sante Publique; 2011 Nov 16; 23(4):305-15. PubMed ID: 22177608
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. NEW technologies for meeting the global demand for pandemic influenza vaccines.
    Fedson DS.
    Biologicals; 2008 Nov 16; 36(6):346-9. PubMed ID: 18715803
    [Abstract] [Full Text] [Related]

  • 58. Antiviral drugs for prophylaxis and treatment of influenza.
    Med Lett Drugs Ther; 2004 Oct 25; 46(1194):85-7. PubMed ID: 15520621
    [No Abstract] [Full Text] [Related]

  • 59. [Human influenza].
    Stock I.
    Med Monatsschr Pharm; 2006 Oct 25; 29(10):360-8; quiz 369-70. PubMed ID: 17058895
    [Abstract] [Full Text] [Related]

  • 60. [Influenza A (H1N1): proposed guideline for hospital management of confirmed or suspected cases].
    Capozzi C, Panà A, Dipartimento di Sanità Pubblica.
    Ig Sanita Pubbl; 2009 Oct 25; 65(2):139-56. PubMed ID: 19529045
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.